LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic

By LabMedica International staff writers
Posted on 08 Dec 2020
Print article
Illustration
Illustration
The global viral RNA extraction kit market is projected to record significant growth in the years to come, driven by the ongoing COVID-19 pandemic as a number of biotech companies race against time to come up with a coronavirus vaccine.

These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.

Viral RNA extraction kits are intended for the purpose of separation of trace amounts of viral RNA from given samples, along with body fluids, plasma, serum, and blood. Additionally, the kits offer high quality outcome of viral Ribonucleic acid (RNA) for the purpose of downstream utilization in various applications, such as alternative PCR-based assays, microarrays, and RT-PCR. These kits are ready to use and are found in a wide variety of formats, such as multi-well, magnetic-based, and spin column for the purpose of better and higher output abilities. Few of the kits also offer synchronal assortment of Deoxyribonucleic acid (DNA).

Increased research and development activities, greater mechanization, and considerable technological progress made in the process of extraction is likely to propel growth of the global viral RNA extraction kit market in the years to come. Additionally, there has been increased demand for various user-friendly products, which is likely to augur well for the market. A surge in cases of various diseases, such as genetic disorders, cancer, dermatological diseases, and infectious diseases, has resulted in increased demand for extraction of viral RNA process in the field of molecular diagnostics. However, significantly low level penetration of products and a dearth of awareness among people in the under-developed markets is likely to limit the growth of the global viral RNA extraction kit market in the years to come. Geographically, the global viral RNA extraction kit market is likely to be dominated by the North America region. Increased government support, technological advancements, and significant R&D in pharmaceutical and biotechnology firms are likely to emerge as important factors for the growth of the North American viral RNA extraction kit market in the near future.

Related Links:
Transparency Market Research

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.